Impact of micro‐mobility‐induced step reduction in healthy adults on vascular and glycemic health: A real‐world investigation
Paul T. Reidy,
Ashley C. Betz,
Jackson P. Yeager,
Yi Liu,
Rachael A. Binion,
Sydney Ayton,
Lauren Lefkowitz,
Eric Slattery,
Rebecca J. Skujins,
Asya Walsh,
Marissa Scerbo,
Kyle L. Timmerman,
Kevin D. Ballard Physiological Reports
· Wiley
· 2026-11-05
· DOI: 10.14814/phy2.71151
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Paul T. Reidy, Ashley C. Betz, Jackson P. Yeager, Yi Liu, Rachael A. Binion, Sydney Ayton et al. Impact of micro‐mobility‐induced step reduction in healthy adults on vascular and glycemic health: A real‐world investigation. // Physiological Reports. – 2026. – DOI: 10.14814/phy2.71151. – URL: https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.71151?af=R
Paul T. Reidy, Ashley C. Betz, Jackson P. Yeager, Yi Liu, Rachael A. Binion, Sydney Ayton, Lauren Lefkowitz, Eric Slattery, Rebecca J. Skujins, Asya Walsh, Marissa Scerbo, Kyle L. Timmerman, & Kevin D. Ballard (2026). Impact of micro‐mobility‐induced step reduction in healthy adults on vascular and glycemic health: A real‐world investigation. Physiological Reports. https://doi.org/10.14814/phy2.71151
Paul T. Reidy, et al. “Impact of micro‐mobility‐induced step reduction in healthy adults on vascular and glycemic health: A real‐world investigation.” Physiological Reports, 2026. doi:10.14814/phy2.71151.
@article{Reidy2026,
title = {Impact of micro‐mobility‐induced step reduction in healthy adults on vascular and glycemic health: A real‐world investigation},
author = {Reidy, Paul T. and Betz, Ashley C. and Yeager, Jackson P. and Liu, Yi and Binion, Rachael A. and Ayton, Sydney and Lefkowitz, Lauren and Slattery, Eric and Skujins, Rebecca J. and Walsh, Asya and Scerbo, Marissa and Timmerman, Kyle L. and Ballard, Kevin D.},
journal = {Physiological Reports},
year = {2026},
doi = {10.14814/phy2.71151},
url = {https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.71151?af=R}
}
ABSTRACT Introduction/Aims Pompe disease is a genetic myopathy caused by acid alpha‐glucosidase enzyme deficiency. Treatment response is mainly evaluated using motor scores, for instance the 6‐min walk test (6MWT) or the Motor Function...
ABSTRACT Introduction/Aims Inflammatory neuropathies (IN), such as Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune...